Concepts (70)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lupus Erythematosus, Systemic | 2 | 2022 | 756 | 0.260 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2022 | 24 | 0.210 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2022 | 25 | 0.200 |
Why?
|
| E2F Transcription Factors | 1 | 2022 | 48 | 0.200 |
Why?
|
| Interleukin-10 | 1 | 2022 | 144 | 0.190 |
Why?
|
| Cancer Vaccines | 1 | 2020 | 61 | 0.170 |
Why?
|
| Up-Regulation | 1 | 2022 | 682 | 0.170 |
Why?
|
| Autoantibodies | 1 | 2022 | 434 | 0.170 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2019 | 34 | 0.160 |
Why?
|
| MicroRNAs | 2 | 2022 | 447 | 0.160 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2019 | 113 | 0.150 |
Why?
|
| Polymethyl Methacrylate | 1 | 2016 | 31 | 0.140 |
Why?
|
| Infant, Premature | 1 | 2019 | 284 | 0.140 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2016 | 28 | 0.140 |
Why?
|
| Drug Carriers | 1 | 2016 | 90 | 0.130 |
Why?
|
| Prenatal Care | 1 | 2016 | 117 | 0.130 |
Why?
|
| Doxorubicin | 1 | 2016 | 231 | 0.130 |
Why?
|
| Biocompatible Materials | 1 | 2016 | 247 | 0.120 |
Why?
|
| Contrast Media | 1 | 2016 | 595 | 0.110 |
Why?
|
| Hospitalization | 1 | 2019 | 978 | 0.110 |
Why?
|
| Risk Assessment | 1 | 2019 | 2007 | 0.100 |
Why?
|
| Health Services Accessibility | 1 | 2016 | 581 | 0.100 |
Why?
|
| Breast Neoplasms | 1 | 2020 | 1536 | 0.090 |
Why?
|
| Mice | 3 | 2022 | 8474 | 0.060 |
Why?
|
| Acetyltransferases | 1 | 2022 | 49 | 0.050 |
Why?
|
| Spermine | 1 | 2022 | 49 | 0.050 |
Why?
|
| Homozygote | 1 | 2022 | 119 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2022 | 124 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2022 | 786 | 0.040 |
Why?
|
| Morbidity | 1 | 2019 | 130 | 0.040 |
Why?
|
| Humans | 6 | 2022 | 68618 | 0.040 |
Why?
|
| Animals | 3 | 2022 | 20881 | 0.040 |
Why?
|
| Young Adult | 2 | 2022 | 5717 | 0.040 |
Why?
|
| Female | 4 | 2022 | 38074 | 0.040 |
Why?
|
| Dendritic Cells | 1 | 2020 | 201 | 0.040 |
Why?
|
| Infant, Premature, Diseases | 1 | 2019 | 85 | 0.040 |
Why?
|
| Gestational Age | 1 | 2019 | 389 | 0.040 |
Why?
|
| Ferrosoferric Oxide | 1 | 2016 | 10 | 0.040 |
Why?
|
| Calibration | 1 | 2016 | 73 | 0.040 |
Why?
|
| Microspheres | 1 | 2016 | 59 | 0.040 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2016 | 127 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2016 | 294 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2020 | 597 | 0.030 |
Why?
|
| Survival Rate | 1 | 2019 | 1056 | 0.030 |
Why?
|
| Fluorocarbons | 1 | 2016 | 82 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2016 | 326 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2016 | 618 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2016 | 567 | 0.030 |
Why?
|
| Kinetics | 1 | 2016 | 1047 | 0.030 |
Why?
|
| Biopsy | 1 | 2016 | 540 | 0.030 |
Why?
|
| Polymers | 1 | 2016 | 244 | 0.030 |
Why?
|
| Health Surveys | 1 | 2016 | 489 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2016 | 453 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2016 | 955 | 0.030 |
Why?
|
| Pancreatic Neoplasms | 1 | 2016 | 332 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 3259 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 1851 | 0.020 |
Why?
|
| Child | 1 | 2022 | 6405 | 0.020 |
Why?
|
| Adult | 2 | 2022 | 21403 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2019 | 3705 | 0.020 |
Why?
|
| Pregnancy | 1 | 2016 | 2334 | 0.020 |
Why?
|
| Male | 2 | 2022 | 37321 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 1070 | 0.020 |
Why?
|
| Adolescent | 1 | 2022 | 8912 | 0.020 |
Why?
|
| Risk Factors | 1 | 2019 | 5731 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 2223 | 0.020 |
Why?
|
| United States | 1 | 2019 | 7367 | 0.020 |
Why?
|
| Aged | 1 | 2022 | 14862 | 0.020 |
Why?
|
| Neoplasms | 1 | 2016 | 1667 | 0.020 |
Why?
|
| Middle Aged | 1 | 2022 | 21147 | 0.010 |
Why?
|